STAT Plus: Novartis battles with the Dutch health minister for raising the price of a cancer drug
DOMINICK REUTER/AFP/GETTY IMAGES
The convoluted case has spurred debate about orphan drug status and the ability of local hospitals to make their own lower-cost alternatives.
.png)
No hay comentarios:
Publicar un comentario